A modified hen egg white lysozyme and its application
By replacing the C-terminal amino acid sequence of egg white lysozyme and introducing cotton, the modified egg white lysozyme and glyphosate resistance genes are formed, and the problem of insufficient disease resistance in the prior art is solved, and efficient disease resistance and resistance are obtained The multi-resistant genetically modified cotton of herbicides simplifies the breeding process.
Patent Information
- Application Number
- CN202111401582.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-19
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2041-11-19
AI Technical Summary
In the prior art, transgenic plants expressing wild-type egg white lysozyme are not disease-resistant and cannot meet the needs of commercial production. The egg white lysozyme protein molecule has not been modified, and the modified egg white lysozyme gene has not been attempted. Cotton is introduced to cultivate genetically modified plants with higher disease resistance.
By replacing the amino acid sequences at positions 98 to 112 of the C-terminal of egg white lysozyme with the corresponding sequence of T4 lysozyme, modifying egg white lysozyme is formed, losing cell wall hydrolase activity but introducing a new α helical domain to enhance bactericidalization and antibacterial activity, and the modified egg white lysozyme gene was introduced into cotton, combining the glyphosate resistance protein gene and T2A polypeptide to form a bivalent fusion protein gene, and obtained multiple methods through Agrobacterium-mediated in vitro stem tip transformation method. Resistant GMO Cotton.
Multi-resistant transgenic cotton with stronger antibacterial activity and herbicide-resistant glyphosate traits were obtained, which simplified the difficulty of building traditional multivalent plant expression vectors, reduced the breeding time and technical difficulty, and had high application value.
Smart Images

Figure CN116144633B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of genetic engineering, and in particular to a modified hen egg white lysozyme and application thereof. Background Art
[0002] Lysozyme was first discovered in nasal mucus in 1922. It is also called muramidase, N-acetylmuramidase, and is an effective antibacterial agent that can act on the β-1,4 glycosidic bond between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) in peptidoglycan, destroying the peptidoglycan scaffold, thereby causing bacterial cell lysis under the action of internal osmotic pressure of the cell; in addition, it can also have a certain inhibitory effect on some plant pathogenic fungi. The lysozyme has a better lysolytic effect on Gram-positive bacteria than on Gram-negative bacteria because negative bacteria contain extracellular lipopolysaccharide (LPS), which can prevent lysozyme from contacting the cell wall. However, studies in recent years have shown that the inhibition of bacterial and fungal cell growth by lysozyme does not depend mainly on its cell wall hydrolysis activity, but mainly on some special amphipathic domains contained in its protein molecules. Although lysozyme no longer has cell wall hydrolase activity after protein denaturation, its antibacterial activity still exists and is even stronger. In addition, lysozyme can also have a certain inhibitory effect on some plant pathogenic fungi whose cell walls do not contain chitin components.
[0003] Lysozyme is widely found in animals, plants and microorganisms in nature. For example, lysozyme is found in human white blood cells, serum, placenta, saliva, tears, milk, uterine mucus and kidneys. It is secreted by monocytes and macrophages and plays a non-specific defense role in the human body. Phages that infect bacterial cells can encode different types of lysozyme. The fresh juice of papaya, pineapple and fig also contains abundant lysozyme. It is speculated that they are also related to the disease resistance of plants.
[0004] Lysozymes can be roughly divided into three types: c-type (hen egg white lysozyme), g-type (goose egg white lysozyme) and phage lysozyme, which have great differences in substrate types and bactericidal activity. Most of the lysozymes discovered so far belong to c-type (such as human and hen egg white lysozyme), and the lysozymes commonly used in production are also extracted and prepared from hen egg white. Phage lysozymes are encoded by various phages that can infect bacterial cells, usually located in the protein capsid of the phage. In the process of infecting host cells, they play an important role in dissolving bacterial cell walls and successfully establishing invasion points.
[0005] Egg white lysozyme is derived from egg white. The content of lysozyme in egg white is very rich, accounting for about 3.4% to 3.5% of the total protein in egg white. As a typical representative of type C lysozymes, it is one of the lysozymes with the clearest structure so far. Mature egg white lysozyme contains 129 amino acid residues and a molecular weight of about 14,300 Da. Because it contains 4 disulfide bonds in the molecule, the protein molecule is relatively stable. When treated at pH 1 to 11 and 100°C for 1 minute, the structure remains unchanged and the lysozyme activity is not lost.
[0006] The application of hen egg white lysozyme in plant disease resistance genetic engineering research began in the early 1990s. For example, Trudel et al. introduced the hen egg white lysozyme gene into tobacco for the first time and subsequently detected lysozyme activity in transgenic plants. Carolina et al. found that transgenic potatoes expressing hen egg white lysozyme had enhanced resistance to bacterial soft rot.
[0007] In addition to egg white lysozyme, in recent years, there have been many reports at home and abroad on the use of lysozyme genes to control bacterial and fungal plant diseases. For example, tobacco expressing human lysozyme genes showed a certain resistance to powdery mildew (Erysiphecichoracearum) and tobacco wildfire pathogen (Pseudomonas syringae pv.tabaci); while radishes expressing the same human lysozyme genes were highly resistant to two other pathogenic fungi (Erysipheheraclei) and (Alternaria dauci).
[0008] Although there have been reports on the application of hen egg white lysozyme in plant disease resistance genetic engineering research, it should be noted that the disease resistance of transgenic plants expressing wild-type hen egg white lysozyme is generally not high and cannot meet the needs of commercial production. Before the present invention, no one has made similar modifications to the hen egg white lysozyme protein molecule, and no one has tried to introduce the modified hen egg white lysozyme gene into cotton to cultivate transgenic plants with higher disease resistance. Summary of the invention
[0009] In order to solve the problems existing in the prior art, the present invention provides modified hen egg white lysozyme and application thereof.
[0010] In a first aspect, the present invention provides a modified hen egg white lysozyme, wherein the modified hen egg white lysozyme is obtained by replacing the amino acid sequence at positions 98 to 112 of the C-terminus of hen egg white lysozyme with the amino acid sequence shown in SEQ ID NO.1.
[0011] T4 lysozyme is a lysozyme with high cell wall hydrolysis activity produced by T4 bacteriophage when it infects Escherichia coli. It is composed of 164 amino acid residues and has a molecular weight of 18,700 Da. Although it does not contain disulfide bonds in the molecule, T4 lysozyme can be stable for 20 hours under environmental conditions of pH 6.0-6.53 and 37°C. The optimal pH value for the enzyme is 7.4-7.7. It can remain stable in the animal stomach (acidic environment), but mainly exerts an antibacterial effect in the intestine.
[0012] The invention replaces the amino acid sequence at positions 98 to 112 of the C-terminus of hen egg white lysozyme with the amino acid sequence at positions 142 to 156 of the C-terminus of T4 lysozyme to obtain a modified hen egg white lysozyme. The modified protein is different from wild hen egg white lysozyme and loses the cell wall hydrolase activity. However, due to the introduction of a new alpha helical structural domain into the molecule, the C-terminus has a greater degree of freedom, so the modified protein has stronger bactericidal and antibacterial activities than the hen egg white lysozyme before the modification. The reason is that this small molecule peptide segment derived from T4 lysozyme is a typical amphipathic helical structure, and the net positive charge contained in the small molecule recognizes each other with the cell membrane with negative charge. After the small molecule peptide segment is inserted into the plasma membrane, the normal physiological metabolism of bacteria or fungal cells can be interfered, thereby achieving the purpose of inhibiting the growth of bacteria and fungi. Therefore, the modified protein has stronger bactericidal and antibacterial activities than the wild type hen egg white lysozyme containing the original beta folded structural domain.
[0013] Furthermore, the amino acid sequence shown in SEQ ID NO.1 contains an α-helical domain.
[0014] Furthermore, the modified hen egg white lysozyme comprises an amino acid sequence as shown in SEQ ID NO.2.
[0015] In a second aspect, the present invention provides a nucleic acid for encoding the modified hen egg white lysozyme.
[0016] Furthermore, the nucleic acid comprises a nucleotide sequence as shown in SEQ ID NO.3.
[0017] The present invention further provides a biological material comprising the nucleic acid, wherein the biological material is an expression cassette, a vector, an engineered bacterium or a transgenic cell.
[0018] For example, the transgenic cell can be a host cell comprising an expression vector comprising the nucleic acid.
[0019] The present invention further provides the use of the modified hen egg white lysozyme, the nucleic acid and the biomaterial in inhibiting microorganisms;
[0020] The microorganism is preferably one or more of Streptococcus, Escherichia coli, Verticillium dahliae or Fusarium wilt.
[0021] Further preferred are Verticillium dahliae and / or Fusarium wilt.
[0022] The present invention further provides the use of the modified hen egg white lysozyme, the nucleic acid, and the biological material in improving cotton's resistance to microorganisms;
[0023] The microorganism is preferably a pathogenic bacterium or a pathogenic fungus, and more preferably one or more of Verticillium dahliae, Fusarium wilt, or bacterial angular leaf spot of cotton.
[0024] In a third aspect, the present invention provides a method for preparing a transgenic plant, comprising: constructing the nucleic acid into an expression vector and transforming the vector into a plant;
[0025] The plant is preferably one or more plants selected from cotton, banana, watermelon or tomato.
[0026] Furthermore, the expression vector also includes a glyphosate resistance protein gene and a T2A polypeptide DNA coding sequence.
[0027] Furthermore, the method comprises constructing the nucleic acid into a recombinant expression vector, then transforming cotton cells, and regenerating complete transgenic cotton from the transgenic cotton cells.
[0028] Further, the method comprises:
[0029] (1) treating the cotton seedlings in the dark for 2 to 3 days, then applying the transformation solution to the stem tip of the cotton seedlings, placing the cotton seedlings in the dark after application, and repeating the process 10 to 15 minutes later;
[0030] The transformation liquid comprises, on the basis of the Agrobacterium bacterial liquid, 2-4% sucrose, 0.05-0.1% surfactant Silwet L-77 and 40-60mg L-1 acetosyringone and silicon dioxide powder with a particle diameter of 150-250 meshes;
[0031] (2) placing the cotton seedlings treated in step (1) in a dark culture at 19-22° C. for 3-4 days, washing away the Agrobacterium, and resuming the culture at 26-30° C. under natural light for 7-10 days, and screening with glyphosate;
[0032] (3) Cultivate at 26-30°C until flowering and seed formation.
[0033] The present invention further provides a transgenic cotton, which comprises the modified hen egg white lysozyme, or the nucleic acid, or the biological material.
[0034] In a fourth aspect, the present invention provides a fusion protein gene, which includes a glyphosate resistance protein gene, a gene encoding the modified hen egg white lysozyme, and a DNA coding sequence of a T2A polypeptide connecting the two.
[0035] Furthermore, the glyphosate resistance protein gene includes the nucleotide sequence shown as SEQ ID NO.4, and the DNA coding sequence of the T2A polypeptide includes the nucleotide sequence shown as SEQ ID NO.5.
[0036] Furthermore, the fusion protein gene includes the nucleotide sequence shown as SEQ ID NO.6.
[0037] In the shikimate pathway in higher plants, 5-enolpyruvyl-shikimate-3-phosphate synthase (EC 2.5.1.19, EPSPS) catalyzes phosphoenolpyruvate (PEP) and shikimate-3-phosphate (Sshikimate-3-phosphate, S3P) to synthesize 5-enolpyruvyl-shikimate-3-phosphate (EPSP), and EPSP is a precursor for the synthesis of aromatic amino acids (phenylalanine, tyrosine, tryptophan). Glyphosate is a structural analog of phosphoenolpyruvate (PEP), which can be used as a competitive inhibitor to first bind to S3P and EPSPS to form a complex, inhibiting the binding of PEP and EPSPS to generate EPSP, thereby blocking the synthesis of aromatic amino acids and achieving the purpose of killing green plants. The donor organism of the CP4-EPSPS protein is the soil Agrobacterium tumefaciens CP4 strain, because it can produce a natural EPSPS protein with low affinity for glyphosate, so that plants overexpressing the CP4-EPSPS protein can be resistant to the herbicide glyphosate.
[0038] The 2A polypeptide was first discovered in the animal foot-and-mouth disease virus (FMDV), so it is called F2A. It is a peptide chain containing only 18 to 20 amino acid residues encoded by an open reading frame in a positive-strand RNA virus. The function of the 2A polypeptide is that when two genes are connected by the 2A polypeptide DNA coding sequence, the 2A polypeptide DNA coding sequence can be transcribed together with the two protein genes connected at both ends to form a long fusion mRNA. When the eukaryotic cell ribosome translates the long chain mRNA, the translated polypeptide breaks at the C-terminus of the 2A polypeptide, and the protein genes at both ends of the 2A polypeptide are independently expressed without the participation of any protease. At present, the 2A polypeptide DNA coding sequence has been identified from a variety of animal viruses. The N-terminal sequences of 2A polypeptides from different sources are quite different, but they all have a conserved sequence composed of three amino acid residues at the C-terminus: proline-glycine-proline (Pro-Gly-Pro). At present, the 2A polypeptides widely used in genetic engineering research include T2A polypeptide encoded by Thosea asigna virus (TaV), E2A polypeptide of equine rhinitis virus (ERAV), P2A polypeptide of porcine teschovirus (PTV-1), and F2A in foot-and-mouth disease virus (FMDV) which was first discovered. The 2A polypeptide used in this patent is T2A. Through the T2A polypeptide DNA coding sequence, the CP4-EPSPS gene and the modified HEWL (T4α4) DNA coding sequence are connected head to tail to form a large bivalent fusion protein gene, and the fusion protein gene is transformed into cotton or other plants, and transgenic plants can be quickly screened by spraying glyphosate.
[0039] The present invention has the following beneficial effects:
[0040] The present invention obtains a modified egg white lysozyme by replacing the amino acid sequence of the 98th to 112th positions of the egg white lysozyme with the amino acid sequence shown in SEQ ID NO.1. Compared with the egg white lysozyme before modification, the modified protein no longer has cell wall hydrolase activity, but has stronger antibacterial activity than the egg white lysozyme before modification, and the antibacterial activity against Escherichia coli and Streptococcus etc. is significantly increased. The present invention also provides a method for rapidly cultivating a new variety of multivalent transgenic cotton. Through the method provided by the present invention, a multi-resistant transgenic cotton with disease resistance and herbicide resistance glyphosate traits can be obtained. The present invention is relatively simple to operate, reduces the difficulty of constructing a traditional multivalent plant expression vector, and the in vivo stem tip transformation method breaks through the limitation of the genotype of the receptor material in the traditional breeding method. Compared with the traditional tissue culture method, the technical difficulty is low, the time consumption is short, and the application value is high. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1The codon optimization and modification of the modified hen egg white lysozyme gene provided in Example 1 of the present invention are compared before and after modification; wherein N represents the HEWL gene sequence before codon optimization and modification, and M represents the HEWL (Tα4) gene sequence after codon optimization and modification.
[0042] Figure 2 The invention provides the cloning of the modified HEWL (T4α4) gene and the construction of its yeast expression vector p9KHEWL (T4α4) in Example 1.
[0043] Figure 3 Schematic diagram of the detection results of SDS-PAGE detection of PP-HEWL (T4α4) high-density fermentation expression products and HEWL (T4α4) recombinant protein after centrifugation, ammonium sulfate precipitation and gel sieve purification provided in Example 2 of the present invention; wherein, M is a standard protein molecular weight marker (Amersham Biosicences product); 1 is the purified HEWL (T4α4) recombinant protein (derived from the induced expression product after PP-HEWL (T4α4) high-density fermentation); 2 is the induced expression product contained in the supernatant after PP-HEWL (T4α4) high-density fermentation (72hr); 3 is the induced expression product of the yeast recombinant transformed with pPIC9K plasmid (72hr) (negative control).
[0044] Figure 4 Schematic diagram for comparing the antibacterial activities of the modified HEWL (T4α4) recombinant protein and the wild-type HEWL provided in Example 3 of the present invention; wherein A is the treatment of Escherichia coli DH5α with the induction expression product of the yeast recombinant transformed by the pPIC9K plasmid (negative control); B is the treatment of Escherichia coli DH5α with the fermentation broth containing the modified HEWL (T4α4) recombinant protein; C is the treatment of Escherichia coli DH5α with the wild-type HEWL; D is the treatment of Streptococcus with the induction expression product of the yeast recombinant transformed by the pPIC9K plasmid (negative control); E is the treatment of Streptococcus with the fermentation broth containing the modified HEWL (T4α4) recombinant protein; F is the treatment of Streptococcus with the wild-type HEWL.
[0045] Figure 5The construction process of the plant expression vector pBI-CP4-T2A-HEWL (T4α4) provided in Example 4 of the present invention; in A in the figure, CP4-EPSPS and HEWL are connected by T2A, and the bivalent fusion protein gene is connected to the 35s promoter and Nos terminator of the pBI121 vector through the two restriction sites of KpnⅠ and XhoⅠ to replace the original GUS gene; GUS represents the β-Glucuronidase gene; CP4-T2A-HEWL (T4α4) represents the fusion protein gene of CP4-EPSPS and HEWL (T4α4), which are connected by the T2A polypeptide coding sequence ( Figure 5 A); B in the figure shows the structural genes and their regulatory expression sequences contained in the plasmid pBI-CP4-T2A-HEWL (T4α4); wherein Nos-Pro represents the nopaline synthase promoter; npt-II represents the neomycin phosphotransferase gene; Nos-Ter represents the nopaline synthase terminator; 35S Pro represents the cauliflower mosaic virus 35S promoter; CP4-T2A-HEWL (T4α4) represents the fusion protein gene of CP4-EPSPS and HEWL (T4α4); RB represents the DNA right border sequence, and LB represents the DNA left border sequence.
[0046] Figure 6 Agarose gel electrophoresis identification of the modified HEWL (T4α4) gene PCR product in the transgenic cotton leaves provided in Example 5 of the present invention; wherein, lanes 1 to 17 are electrophoresis bands of the HEWL (T4α4) gene in the cotton leaves with glyphosate resistance, indicating that transgenic plants No. 1 to 17 all contain the HEWL (T4α4) target gene; lane 18 is a non-transgenic cotton leaf without a specific band (negative control); lane 19 is a PCR amplification product of the plant expression vector plasmid DNA containing a bivalent fusion gene as a positive control; lane M is a DNA Marker.
[0047] Figure 7 A schematic diagram of the Western-blot identification results of the modified HEWL (T4α4) protein in the transgenic cotton leaves provided in Example 5 of the present invention; wherein, lanes 1 to 2 are Western-blot bands of the modified HEWL (T4α4) protein in the cotton leaves with glyphosate resistance; lane 3 is a non-specific band in the non-transgenic cotton leaves (negative control); lane 4 is a Western-blot band of the HEWL protein standard (positive control); lane M is a Protein Marker.
[0048] Figure 8Schematic diagram of the results of identification of resistance to Verticillium wilt of transgenic cotton provided in Example 5 of the present invention; wherein A is a silver-resistant P53 plant that has not been inoculated with Verticillium wilt Vd991; B is a silver-resistant P53 plant that has been inoculated with Verticillium wilt Vd991; C and D are transgenic cotton plants that have been inoculated with Verticillium wilt Vd991. DETAILED DESCRIPTION
[0049] The following examples are used to illustrate the present invention but are not intended to limit the scope of the present invention.
[0050] Embodiment 1:
[0051] 1. Artificial synthesis of the modified hen egg white lysozyme HEWL (T4α4) gene after codon optimization
[0052] Egg white lysozyme is derived from mammals, and its codons are close to those of plants, but they are different. This difference is likely to affect the stability and expression efficiency of the modified egg white lysozyme gene and its transcription product in plant cells. In order to improve its biological yield, the present invention is based on the published DNA sequence and amino acid sequence of the mature egg white lysozyme gene (GenBank, accession number: NM_205281.1), except for the 98th to 112th amino acid sequence, under the premise of not changing other amino acid sequences (the amino acid sequence of the modified egg white lysozyme is shown in SEQ ID NO.1), according to the codons preferred by plants, artificially designed and synthesized a new modified egg white lysozyme HEWL (T4α4) DNA coding sequence, compared with the egg white lysozyme before the modification, the codon optimized and modified egg white lysozyme has changed 111 nucleotide bases, involving a total of 71 codons, and the G+C content has changed from the original 57.2% to the current 46.4%. The comparison before and after the gene modification is shown in the attached figure. Figure 1 .
[0053] 2. Construction of yeast expression vector p9KHEWL (T4α4)
[0054] 2.1 Cloning of modified HEWL (T4α4) gene
[0055] The synthesis of the modified HEWL (T4α4) gene was completed by Nanjing GenScript Biotechnology Co., Ltd., and the synthesized gene was stored in the universal cloning vector PUC57. In order to facilitate the construction of the yeast expression vector, a pair of primers HEWL-YF and HEWL-YR were synthesized with reference to the modified HEWL (T4α4) gene sequence. The primer sequences are as follows:
[0056] HEWL-YF: 5'-CTCGAGAAAAGAAAGGTTTTCGGTAGATGTGAGTTG-3';
[0057] HEWL-YR: 5'-GCGGCCGCTTACAATCTACAACCTCTGATCCAG-3'.
[0058] Primer HEWL-YF: contains the 5' end partial nucleotide sequence of HEWL (T4α4), and the restriction enzyme site Xho I and the yeast Kex2 gene expression product cleavage recognition sequence CTCGAGAAAAGA are synthesized and added before the first start codon AAG at the 5' end of the gene; in primer HEWL-YR, contains the 3' end partial nucleotide sequence of HEWL (T4α4), and the restriction enzyme site Not I is added after the stop codon TAA. The plasmid DNA containing the HEWL (T4α4) gene PUC57-HEWL (T4α4) was used as a template to perform PCR amplification using the above primer pair.
[0059] The PCR reaction system was: plasmid template 1 μL, HEWL-YF primer 1 μL (10 μM), HEWL-YR 1 μL (10 μM), dNTP 2 μL (2.5 mM), 10× buffer 5 μL, Taq polymerase 1 μL, ddH2O 39 μL.
[0060] The PCR reaction conditions were as follows: pre-denaturation at 94°C for 1 min, denaturation at 94°C for 30 sec, annealing at 56°C for 30 sec, extension at 72°C for 2 min, 30 cycles, and extension at 72°C for 10 min.
[0061] After the PCR product was recovered by agarose gel, it was ligated into the T site of the pEASY-T1 (purchased from Beijing TransGenic Company) plasmid. According to the method provided by the company, a bacterial clone containing the intermediate plasmid vector pT1-HEWL (T4α4) was obtained. Then, DNA sequencing was used to determine whether the modified HEWL (T4α4) gene contained therein was correct and complete (DNA sequencing was completed by Beijing BiaoKai Technology Co., Ltd.).
[0062] 2.2 Construction of yeast expression vector p9KHEWL (T4α4)
[0063] After the pT1-HEWL(T4α4) plasmid DNA was double-digested with Xho I and Not I, the modified HEWL(T4α4) gene fragment was cut out and separated by agarose gel electrophoresis. The DNA fragment was then inserted into the plasmid pPIC9K (double-digested with Xho I and Not I) to construct the yeast inducible expression vector p9KHEWL(T4α4) (see Figure 2 ).
[0064] Plasmid pPIC9K was purchased from Invitrogen, USA. It is an efficient yeast inducible expression vector that can efficiently express foreign genes under the induction of methanol. Because the expression vector contains an α-factor signal peptide coding sequence before the multiple restriction sites, after fusion expression with the foreign protein gene, the foreign recombinant protein can be guided to secrete into the yeast extracellular space. During the secretion process, the signal peptide sequence can be completely cut off by the yeast Kex2 or Ste13 gene expression product, so that the structure and bactericidal activity of the modified HEWL (T4α4) recombinant protein will not be affected at all.
[0065] 3. Transformation and modification of Pichia pastoris and purification of HEWL (T4α4) recombinant protein
[0066] 3.1 Preparation of plasmid DNA of p9KHEWL (T4α4)
[0067] First, p9KHEWL (T4α4) plasmid DNA was extracted from Escherichia coli DH5α cells (purchased from GIBCO, USA) by alkaline lysis method, and then the plasmid DNA was digested with 1-2 times excess restriction endonuclease Bgl II to make it completely linear. Agarose gel electrophoresis can be used to detect whether the digestion is complete. Then, the digestion products were extracted with phenol and chloroform, ethanol precipitated, freeze-dried, and then the precipitate was redissolved in sterile deionized water and stored in a -20°C refrigerator for later use.
[0068] 3.2 Transformation of Pichia pastoris cells
[0069] A single colony of Pichia pastoris strain GS115 (purchased from Invitrogen, USA) was picked and inoculated into 5 mL of YPD medium (1% yeast extract, 2% tryptone, 2% glucose), and cultured at 30°C with shaking overnight. 0.5 mL of the culture solution was taken out and inoculated into 500 mL of YPD medium, and cultured at 30°C with shaking until OD 600nm The light absorption value was about 1.4 to 1.5, and the yeast cells were collected by centrifugation at 4000 rpm and 4°C for 2 minutes.
[0070] The precipitated yeast cells were resuspended in 500 mL of sterile water in an ice bath, and then centrifuged at 4000 rpm for 2 minutes at 4°C to collect the yeast cells again. The above washing process was repeated once. The precipitated yeast cells were resuspended with 25 mL of 1 mol / L sorbitol in an ice bath, and the yeast cells were collected by centrifugation as above, and the precipitated yeast cells were resuspended with 0.5 mL of 1 mol / L sorbitol in an ice bath, and 80 uL of yeast competent cells were taken out, and they were fully mixed with the linearized plasmid vector DNA (4-5 ug) prepared above, and then transferred to a 0.2 cm sterile electric shock cup after an ice bath.
[0071] Micropulser TM (BioRad product) Linearized plasmid DNA was introduced into yeast competent cells, and the electroporation parameters used were 0.8kv, 11.5uF. After the electroporation was completed, 0.8mL of 1mol / L sorbitol solution in an ice bath was immediately added to the electroporation cup, and after thorough mixing, the bacterial solution was coated on RDB [1.34% Yeast Nitrogen Base With Ammonium Sulfate without amino acids (YNB) (Sigma product), 1mol / L sorbitol, 1% glucose, 0.00004% Biotin, 0.005% glutamic acid, 0.005% methionine, 0.005% lysine, 0.005% leucine, 0.005% isoleucine, 1.5% agar] solid plate culture medium at a volume of 200ul per plate, and the plate was inverted and placed in a 30°C incubator for culture until the transformed recombinants appeared.
[0072] Use a sterile toothpick to pick up a single yeast colony (recombinant) newly grown on the RDB solid plate medium, and spot it on MM (1.34% YNB, 0.00004% Biotin, 0.5% methanol, 1.5% agar) and MD (1.34% YNB, 0.00004% Biotin, 2% glucose, 1.5% agar) solid plate medium respectively; culture at 30°C for 2 days. If the growth on MM and MD is the same, its phenotype is Mut + The cells grow normally on MD and grow slowly or not at all on MM, and the phenotype is Mut s .
[0073] 3.3 Screening of high-expression Pichia pastoris strains
[0074] The transformants that grew normally on the MD plate but slowly on the MM plate were picked up, inoculated into 5 mL of BMGY [1% yeast extract, 2% tryptone, 100 mmol / L potassium phosphate buffer (pH 7.0), 1.34% YNB, 0.00004% Biotin, 1% glycerol (V / V)] liquid medium (the medium used glycerol as the carbon source), cultured at 30°C in a shaking incubator for 2 days, centrifuged at 4000 rpm for 2 min, and the supernatant was removed; the bacteria were resuspended in 1 mL of BMMY [1% yeast extract, 2% tryptone, 100 mmol / L potassium phosphate buffer (pH 7.0), 1.34% YNB, 0.00004% Biotin, 0.5% methanol] liquid medium (the medium used methanol as the exogenous protein gene expression inducer), and induced culture was carried out at 30°C for 4 days; the culture was incubated at 10000 rpm for 2 min. Centrifuge at 4°C for 5 min and collect the supernatant containing the recombinant protein of HEWL (T4α4). The supernatant can be directly used for the determination of bactericidal activity.
[0075] The bactericidal activity of the modified HEWL (T4α4) recombinant protein was detected in full accordance with the colony counting method reported by Düring et al. A single colony of the Streptococcus strain (strain code: 1.2499, purchased from the Culture Collection Center of the Institute of Microbiology, Chinese Academy of Sciences) was picked and inoculated into 5 mL LB (5 g yeast extract, 10 g tryptone, 10 g NaCl, add water to 1 L, pH 7.0) liquid culture medium and cultured at 37°C with shaking overnight.
[0076] The next day, collect the bacterial culture solution, centrifuge at 5000g for 5 minutes at room temperature, and collect the precipitate (bacteria). Suspend the precipitate in 1×PBS (8gNaCl, 0.2gKH2PO4, 2.9gNa2HPO4·12H2O, 0.2gKCl, add distilled water to 1L) buffer, centrifuge again (same as above) to collect the bacteria. Resuspend the bacteria in 0.1XPBS buffer and adjust the bacterial concentration to 2×10 7 / mL. Add 200μL of yeast fermentation solution to every 200μL of the above bacterial solution, place at 37℃ for 1 hour, then dilute the bacterial solution 10,000 times, take out 200μL of the bacterial solution and spread it on the LB solid plate, culture at 37℃ overnight, and the next day, the expression level of the modified HEWL (T4α4) recombinant protein can be judged according to the number of colonies formed.
[0077] The streptococcal culture treated with BMMY medium was used as a negative control. The results showed that the methanol-induced culture of some recombinant yeast strains obtained by transformation with p9KHEWL (T4α4) plasmid DNA could indeed reduce the number of colonies that streptococci could form. It can be concluded that the modified HEWL (T4α4) recombinant protein expressed in yeast has bactericidal activity.
[0078] According to the reduction in the number of streptococcal colonies, the yeast strain with the highest expression efficiency of the modified HEWL (T4α4) recombinant protein (the least number of streptococcal colonies) was selected from multiple yeast recombinants and named PP-HEWL (T4α4).
[0079] Example 2
[0080] This implementation is aimed at large-scale production of modified HEWL (T4α4) recombinant protein, and the specific process is as follows:
[0081] 1. Preparation of seed solution
[0082] Single colonies of PP-HEWL (T4α4) yeast provided in Example 1 were picked from the RDB solid plate, inoculated into 10 mL of YPD liquid culture medium, shake-cultured at 30° C. overnight, transferred into 100 mL of YPD liquid culture medium at a 10% inoculation rate, shake-cultured at 30° C. for 24 hours, and then transferred into 1 L of BMGY culture medium at a 10% inoculation rate, shake-cultured at 30° C. for 24 hours, and then used as seed liquid.
[0083] 2. High-density fermentation of recombinant yeast in a 20L fermenter
[0084] The fermentation process can be divided into the following three stages: 1) Bacterial culture stage: 10L of basic fermentation medium [10×Basal Salts (2.67% phosphoric acid, 0.093% calcium sulfate, 1.82% potassium sulfate, 1.49% magnesium sulfate, 0.413% potassium hydroxide) + 4% glycerol] was placed in a 20L fermentation tank (product of Shanghai Baoxing Bio-Equipment Engineering Co., Ltd.), and 28% ammonia water was added before inoculation to maintain the pH value of the culture medium at about 7.5 (ammonia water can also be used as a nitrogen source for yeast cell growth), and then 4.37mL of trace salt solution PTM1 (0.6% copper sulfate, 0.008% sodium iodide, 0.3% manganese sulfate, 0.02% sodium molybdate, 0.002% boric acid, 0.05% cobalt chloride, 2% zinc chloride, 6.5% ferrous sulfate, 0.025% biotin, 0.5% sulfuric acid) was added to each liter of basic fermentation medium according to the following proportions. Inoculate the previously prepared seed solution at a ratio of 10%, and culture at 30°C with aeration and stirring for about 24 hours. During this stage, as the bacteria grow, the dissolved oxygen content in the culture medium will gradually decrease from 100%. When the carbon source in the culture medium is consumed, the dissolved oxygen content will rise again to more than 80%, and the wet weight of the bacteria will reach 90-95g / L.
[0085] 2) Carbon source feeding stage: Feeding liquid is added by peristaltic pump, the feeding liquid is 50% glycerol (containing 12mL PTM1 / L), and the flow rate is 18.15mL / hr / L. Cultivate with aeration and stirring at 30℃ for about 4 hours. At this stage, the ventilation volume is adjusted so that the dissolved oxygen content is always greater than 20%. At this time, the wet weight of the bacteria will reach about 180-190g / L.
[0086] 3) Induction expression stage: Methanol (containing 12mL / L PTM1) was added to maintain the methanol concentration at about 0.3% and the dissolved oxygen content at more than 20%. The culture was stirred and aerated at 30°C for 108 hours. At this time, the expression of the recombinant HEWL (T4α4) protein reached the highest peak. Several milliliters of the fermentation broth were centrifuged at 5000rpm and 4°C for 10 minutes. 20uL of the fermentation supernatant was taken from each of the PP-HEWL (T4α4) fermentation products for SDS-PAGE electrophoresis. It was found that there was only one protein band observable to the naked eye in the PP-HEWL (T4α4) lane, with a molecular weight of about 14KD, which was consistent with the molecular weight of the recombinant HEWL (T4α4) protein in the speculation (e.g. Figure 3 The protein purity can reach more than 99%.
[0087] 3. Purification of modified HEWL (T4α4) recombinant protein
[0088] After a fermentation cycle is completed, 500 mL of fermentation liquid is retained as seed liquid (inoculation amount is 5%) to directly carry out the next round of fermentation process. Similar operations are carried out for 3 rounds in total. In each round of fermentation, the growth of the bacteria and the expression of HEWL (T4α4) recombinant protein are measured. In addition, after each round of fermentation is completed, a small amount of bacterial liquid is spread on YPD solid plate medium, and 10 single colonies are randomly selected from them. The genomic DNA is quickly extracted and PCR is performed on them in full accordance with the method of Cai Chuanqi et al. The results show that the biomass, growth rate and expression of HEWL (T4α4) recombinant protein of the bacteria remain basically stable during each round of fermentation. In addition, the PCR test results also confirm that PP-HEWL (T4α4) has good genetic stability (see Table 1).
[0089] Table 1 Determination of genetic stability and exogenous protein expression stability of PP-HEWL (T4α4) strain
[0090] Algebra PCR positive 24h wet weight of bacteria (g / L) Expression level of modified HEWL (T4α4) protein at 72h (g / L) 1 100% 95 0.01 2 100% 95 0.01 3 100% 97 0.01
[0091] After a fermentation cycle, except for 500 mL of fermentation liquid as seed liquid, the rest of the fermentation liquid was centrifuged at 5000 rpm for 10 minutes at 4°C, and the supernatant was retained. Solid ammonium sulfate was added to the mixture until the saturation reached 80%, stirred at room temperature for 1 hour, and then centrifuged at 5000 rpm for 20 minutes at room temperature, and the precipitate was collected, and the precipitate was resuspended in 10 mL of 100 mM Tris-HCl (pH 8.0) buffer and transferred to a dialysis bag, and then dialyzed against 1 L of 100 mM Tris-HCl (pH 8.0) buffer at 4°C to remove the remaining ammonium sulfate, and the outer dialysate was replaced three times during the 24-hour dialysis time. After the dialysis was completed, the dialyzate was sucked out of the dialysis bag, and then the dialyzate was further purified through a Sephadex G-75 molecular sieve gel column (Sephadex G-75 purchased from Amersham Biosciences) according to the method of Ausubel et al., and the column volume used was 80X1.5 cm. After loading, elution was performed with 100 mM Tris-HCl (pH 8.0) buffer, and the eluate was collected in 2 mL portions.
[0092] The lysozyme activity of each part of the eluate was detected by the colony counting method (see step 3 of Example 1), and then all the eluate parts that can reduce the number of colonies were pooled together, and ammonium sulfate was added again to a final concentration of 80% for precipitation and dialysis, and the method was the same as above. The dialyzate in the dialysis bag was transferred to a drying bottle, and after freeze-drying, the precipitate was resuspended in a certain amount of sterilized deionized water. The protein purity was found to be more than 99% (such as Figure 3 In addition, the bactericidal activity of the modified HEWL (T4α4) recombinant protein was not lost after being subjected to the above two ammonium sulfate precipitations, dialysis and column chromatography for a long time.
[0093] The protein content was determined using the Lowry method (protein assay kit purchased from Sigma, catalog number P5656) (see the kit instructions for the specific method), and the recombinant protein content of the modified HEWL (T4α4) was approximately 0.01 g / L (the average value of three high-density fermentations).
[0094] Example 3
[0095] This example is aimed at comparing the antibacterial activity of the modified HEWL (T4α4) recombinant protein with that of the wild-type HEWL. The specific process is as follows:
[0096] 1. Determination of cell wall hydrolysis activity of modified HEWL (T4α4) recombinant protein
[0097] Prepare Escherichia coli (DH5α) lyophilized powder according to the method of Tsugita A et al. Weigh 50 mg of lyophilized powder and resuspend it in 100 mL of 0.05 M Tris-HCL buffer (pH 7.4). Add egg white lysozyme standard (purchased from Beijing Zeping Technology Co., Ltd.) and modified HEWL (T4α4) recombinant protein to each 50 mL of bacterial suspension to a final concentration of 20 ug / mL, react at 37°C for 5 minutes, and then detect the light absorption value at 350 nm. The test results are shown in Table 2. After the wild-type hen egg white lysozyme (HEWL) was incubated with the Escherichia coli substrate, it could degrade the cell wall substrate, and the light absorption value decreased from 0.71 before addition to 0.40. However, in the treatments with the addition of bovine serum albumin (BSA) [purchased from Sangon Biotech (Shanghai) Co., Ltd.] (negative control) and the modified hen egg white lysozyme, the OD value did not change at all, indicating that the modified hen egg lysozyme no longer had any cell wall hydrolysis activity.
[0098] Table 2 Determination of cell wall hydrolysis activity of modified HEWL (T4α4)
[0099]
[0100] Note: The numbers in the table are the average values of three tests.
[0101] 2. Comparison of antibacterial activity between modified HEWL (T4α4) recombinant protein and wild-type HEWL
[0102] The purified modified HEWL (T4α4) recombinant protein was adjusted to the same working concentration with 0.1×PBS buffer, and the antibacterial activity was detected by the same colony counting method (see step 3 in Example 1 for specific operations), and the strains tested were Streptococcus (strain code: 1.2499, purchased from the Culture Collection Center of the Institute of Microbiology, Chinese Academy of Sciences) and Escherichia coli DH5α (purchased from GIBCO, USA). The test results showed that the modified HEWL (T4α4) recombinant protein could reduce the number of colonies formed by the two tested strains, and the antibacterial activity was increased by about 40% or more than that of the wild-type HEWL, while Streptococcus was more sensitive to the HEWL (T4α4) recombinant protein, and its inhibited activity was increased by about 54% compared with that of the wild-type HEWL (see Figure 4 ).
[0103] Table 3 Comparison of bactericidal activity of different T4 lysozyme recombinant proteins
[0104] strain Modified HEWL (T4α4) recombinant protein Wild type HEWL Streptococcus 14 31 Escherichia coli 23 39
[0105] Note: The number of colonies formed by adding 0.1× PBS buffer is 100. The numbers in the table are the relative number of colonies remaining after adding different lysozyme proteins, and are the average values of three experiments.
[0106] Example 4
[0107] This example is about the construction and transformation of the plant expression vector pBI-CP4-T2A-HEWL (T4α4), and the specific process is as follows:
[0108] 1. Cloning of CP4-EPSPS and modified HEWL (T4α4) genes
[0109] The synthesis of CP4-EPSPS and modified HEWL (T4α4) genes was completed by Nanjing GenScript Biotechnology Co., Ltd. The synthesized genes were stored in the universal cloning vector PUC57 and named pUC-CP4-EPSPS and pUC-HEWL (T4α4) respectively. In order to facilitate the construction of bivalent plant expression vectors, two pairs of primers CP4-EPSPS-PF, CP4-EPSPS-PR, HEWL-PF and HEWL-PR were synthesized with reference to the CP4-EPSPS gene, T2A polypeptide coding sequence and modified HEWL (T4α4) gene sequence. The primer sequences are as follows:
[0110] CP4-EPSPS-PF:5'-GGTACCATGGCACAAATTAACAACATGGCACAAGGG-3',
[0111] CP4-EPSPS-PR: 5'-AGGACCAGGGTTTTTCTTCAACATCACCGCAAGTAAGAAGAGAACCTCT ACCTTCGGCAGCCTTCGTATCGGAGAGTTCGATCTT-3';
[0112] HEWL-PF: 5'-GAAGGTAGAGGTTCTCTTCTTACTTGCGGTGATGTTGAAGAAAACCCTGGTC CTAAGGTTTTCGGTAGATGTGAGTTGGCTGCC-3',
[0113] HEWL-PR: 5'-CTCGAGGCGGCCGCTTACAATCTACAACCTCTGATCCAG-3'.
[0114] Primer CP4-EPSPS-PR and primer HEWL-PF are reverse complementary sequences, both of which contain T2A coding sequences. The reverse complementary sequences are used for homologous recombination between DNA fragments to form a bivalent fusion protein gene. A KpnⅠ restriction enzyme site is added to the 5' end of primer CP4-EPSPS-PF, and an XhoⅠ restriction enzyme site is added to the 5' end of primer HEWL-PR. These two restriction enzyme sites are used to connect the bivalent fusion protein gene with the plant expression vector pBI121. The pUC-CP4-EPSPS and pUC-HEWL (T4α4) plasmids containing the above two target gene DNA sequences were used as templates, and the target genes were amplified by PCR using the corresponding primers.
[0115] The PCR reaction system was: plasmid template 1 μL, 5' end primer 1 μL (10 μM), 3' end primer 1 μL (10 μM), dNTP 2 μL (2.5 mM), 10× buffer 5 μL, Taq polymerase 1 μL, ddH2O 39 μL.
[0116] The PCR reaction conditions were as follows: pre-denaturation at 94°C for 1 min, denaturation at 94°C for 30 sec, annealing at 56°C for 30 sec, extension at 72°C for 2 min, 30 cycles, and extension at 72°C for 10 min.
[0117] After the PCR products were recovered by agarose gel, 1 μL of each of the recovered products was taken, and the mixture was used as a template, CP4-EPSPS-PF and HEWL-PR were used as primers to PCR amplify the full-length fusion gene, and the PCR reaction conditions were the same as above. The PCR product was connected to the T site in the pEASY-T1 (purchased from Beijing TransGenic Company) plasmid, and according to the method provided by the company, a bacterial clone containing the intermediate plasmid vector pT1-CP4-T2A-HEWL (T4α4) was obtained, and then, by DNA sequencing, it was determined that the bivalent fusion protein gene contained therein was correct and complete (DNA sequencing was completed by Beijing Biaokai Technology Co., Ltd.).
[0118] 2. Construction of plant expression vector pBI-CP4-T2A-HEWL (T4α4)
[0119] The pT1-CP4-T2A-HEWL (T4α4) vector containing the bivalent fusion protein gene constructed above was double-digested with XhoⅠ and KpnⅠ, and the plant expression vector pBI121 was double-digested in the same way. The enzyme fragments of the fusion protein gene and the vector were recovered respectively, and the recovered products were connected. The connection system was 5μL of fusion gene, 3μL of vector, 2μL of 5× buffer, and 1μL of T4 DNAligase. The connection conditions were 16℃ overnight. The connection product was transformed into Escherichia coli cloning competent cells. The positive single clone obtained was sequenced correctly, indicating that the plant expression vector containing the bivalent fusion protein gene was constructed. The vector map is shown in the figure. Figure 5 As shown, the plasmid was extracted and electrotransformed into Agrobacterium EHA105 for later use.
[0120] 3. Transform the bivalent fusion protein gene into cotton through Agrobacterium-mediated in vitro stem tip transformation
[0121] 1) Select silver-resistant P53 insect-resistant cotton varieties, sow them in a greenhouse, and keep them in the dark for 2 to 3 days after germination for transformation;
[0122] 2) The engineered Agrobacterium EHA105 containing the fusion gene was stored on a solid LB plate supplemented with 50 mg l-1 kanamycin and 20 mg l-1 rifampicin, 4-5 clones of the engineered Agrobacterium were selected and cultured in a liquid LB medium containing 50 mg l-1 kanamycin and 20 mg l-1 rifampicin, shaken and cultured overnight at 28°C, centrifuged at 4000 rpm and 4°C for 5 min, the supernatant was discarded, and the cell concentration of the engineered Agrobacterium was adjusted to OD600 = 0.6-1.0 by resuspending in MS liquid medium; 0.5 mL Silwet L-77, 40 mg acetosyringone and silicon dioxide were added to each liter of Agrobacterium-MS solution for later use;
[0123] 3) Place the above liquid in the spray bottle of the spray gun and mix it thoroughly. When the pressure reaches 7×105 Pa, spray the cotton stem tip (including the growth point). After transformation, immediately carry out dark treatment; ten minutes later, repeat the infection process; after culturing in the dark at 19-22°C for 3 days, rinse the cotton plants with sterile water containing cephalosporin, and resume culturing at 26-30°C under light for 7-10 days. After the true leaves appear, spray glyphosate at a concentration slightly lower than the critical concentration for preliminary screening. Thereafter, spray glyphosate at a critical concentration every 30 days. Most of the treated cotton plants die, and the very few normal green cotton plants with no symptoms of herbicide damage are glyphosate-resistant plants, and the seeds they produce are T0 generation cotton seeds.
[0124] Example 5
[0125] This example conducts molecular biological detection on T0 generation transgenic cotton plants, and the specific process is as follows:
[0126] 1. PCR detection of genetically modified cotton
[0127] 1) After sowing, T0 cotton seeds grew to the 4-leaf stage, and their genomic DNA was extracted by CTAB method, and PCR detection of HEWL target gene was performed. The primers HEWL-F and HEWL-R were used. The primer sequences, PCR system and reaction conditions were the same as those in Example 1. Non-transgenic cotton leaf genomic DNA was used as a negative control, and the plant expression vector plasmid DNA containing the bivalent fusion protein gene was used as a template for the positive control. The PCR product was detected by 1% agarose gel electrophoresis. The electrophoresis detection results were as follows: Figure 6 As shown, it was confirmed that the HEWL (T4α4) exogenous protein gene had been transformed into cotton plants.
[0128] 2. Western-blot detection of genetically modified cotton
[0129] The Western-blot method was used to detect the expression of the modified HEWL (T4α4) gene. HEWL protein standards were purchased from Beijing Zeping Technology Co., Ltd., and HEWL polyclonal antibodies were prepared by Beijing Huada Protein Research and Development Center Co., Ltd.; alkaline phosphatase-labeled rabbit secondary antibodies were purchased from Abcam (Shanghai) Trading Co., Ltd. Cotton leaf protein extraction was carried out using a plant protein extraction kit (Sangon Biotechnology (Shanghai) Co., Ltd.), non-transgenic cotton leaves were used as negative controls, and protein standards were used as positive controls. Western-blot test results are shown in Figure 2. Figure 7 As shown, it was confirmed that the modified HEWL (T4α4) was expressed in the transgenic cotton plants.
[0130] 2. Verticillium wilt resistance detection of T0 transgenic cotton plants
[0131] 2.1 Cultivation of Verticillium dahliae
[0132] The Verticillium dahliae kleb Vd991 strain was kindly donated by Jian Guiliang, a researcher at the Institute of Plant Protection, Chinese Academy of Agricultural Sciences. The Verticillium dahliae kleb (Vd991) strain stored at -80°C was inoculated on PDA solid medium and incubated in an inverted incubator at 28°C for 5-7 days until the hyphae covered the entire plate. The surface of the plate was rinsed with sterile water.
[0133] Collect the spore solution, calculate the spore concentration using a hemocytometer, and adjust the concentration to 5×10 6 cfu / mL, for future use.
[0134] 2.2 Inoculation of transgenic cotton using root irrigation
[0135] Mix the purchased vermiculite and flower fertilizer soil in a ratio of 1:1 and put them into a 10×5 hole seedling pot. Sow the test cotton seeds that have been delinted with concentrated sulfuric acid and disinfected with 30% H2O2 in the seedling pot. When sowing, sow 2 seeds evenly in each hole, press gently, cover with 1.5-2.0cm of the same vermiculite sand, and smooth and suppress appropriately. Water appropriately every morning after sowing, and raise seedlings under room temperature and light conditions. Inoculate when the cotton seedlings have at least 2-3 true leaves. Before inoculation, pull out small and weak seedlings, and try to leave neat and consistent seedlings. Do not water or water less the day before inoculation to prevent the seedlings from absorbing too much water and affecting their absorption of bacterial solution. When inoculating, take out the seedlings with soil from the holes of the seedling pot, invert the wounded roots, pour 20mL of spore solution from top to bottom to the roots, and then put the cotton seedlings back into the pots with mixed soil in advance. Water appropriately every 2 days and observe the disease of cotton regularly. The results showed that the negative control plants (silver-resistant P53) generally began to develop lesions on the lower leaves of cotton 7 days after inoculation, and the leaves gradually withered. As time went on, the hyphae in the plant began to spread upward along the vascular bundles, and the upper leaves also began to become diseased. At 20 days after inoculation, the non-resistant plants were basically all diseased (such as Figure 8 As shown in the figure, the leaves of the P53 plants inoculated with the fungus were seriously diseased, and the whole plant was diseased, while the uninoculated P53 plants and the transgenic cotton plants showed no symptoms of disease; one month after inoculation, the negative control P53 plants had withered and died, while the transgenic disease-resistant plants were still growing well, indicating that cotton carrying the HEWL (T4α4) gene had good resistance to Verticillium dahliae.
[0136] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention. Sequence Listing <110> Institute of Biotechnology, Chinese Academy of Agricultural Sciences <120> A modified hen egg white lysozyme and its application <130> KHP211122490.2 <160> 12 <170> SIPOSequenceListing 1.0 <210> 1 <211> 13 <212> PRT <213> Artificial Sequence <400> 1 Pro Asn Arg Ala Lys Arg Val Ile Thr Thr Phe Arg Thr 1 5 10 <210> 2 <211> 129 <212> PRT <213> Artificial Sequence <400> 2 Lys Val Phe Gly Arg Cys Glu Leu Ala Ala Ala Met Lys Arg His Gly 1 5 10 15 Leu Asp Asn Tyr Arg Gly Tyr Ser Leu Gly Asn Trp Val Cys Val Ala 20 25 30 Lys Phe Glu Ser Asn Phe Asn Thr Gln Ala Thr Asn Arg Asn Thr Asp 35 40 45 Gly Ser Thr Asp Tyr Gly Ile Leu Gln Ile Asn Ser Arg Trp Trp Cys 50 55 60 Asn Asp Gly Arg Thr Pro Gly Ser Arg Asn Leu Cys Asn Ile Pro Cys 65 70 75 80 Ser Ala Leu Leu Ser Ser Asp Ile Thr Ala Ser Val Asn Cys Ala Lys 85 90 95 Lys Thr Pro Asn Arg Ala Lys Arg Val Ile Thr Thr Phe Arg Thr Gly 100 105 110 Asn Arg Cys Lys Gly Thr Asp Val Gln Ala Trp Ile Arg Gly Cys Arg 115 120 125 Leu <210> 3 <211> 390 <212> DNA <213> Artificial Sequence <400> 3 aaggttttcg gtagatgtga gttggctgcc gctatgaaga gacacggttt ggacaactac 60 agaggttact ccttgggtaa ctgggtttgt gttgccaagt tcgagtctaa cttcaacacc 120 caagctacta acagaaacac cgacggttct accgactacg gtatcttgca aatcaactcc 180 agatggtggt gtaacgacgg tagaacccca ggttccagaa acttgtgtaa catcccatgt 240 tccgctttgt tgtcctctga catcactgct tccgttaact gtgccaagaa gactccaaac 300 agagctaaga gagttatcac tactttcaga actggtaaca gatgtaaggg tactgacgtc 360 caagcctgga tcagaggttg tagattgtaa 390 <210> 4 <211> 1635 <212> DNA <213> Artificial Sequence <400> 4 atggcacaaa ttaacaacat ggcacaaggg atacaaaccc ttaatcccaa ttccaatttc 60 cataaacccc aagttcctaa atcttcaagt tttcttgttt ttggatctaa aaaactgaaa 120 aattcagcaa attctatgtt ggttttgaaa aaagattcaa tttttatgca aaagttttgt 180 tcctttagga tttcagcatc agtggctaca gcctgcatgc ttcacggtgc aagcagccgg 240 cccgcaaccg cccgcaaatc ctctggcctt tccggaaccg tccgcattcc cggcgacaag 300 tcgatctccc accggtcctt catgttcggc ggtctcgcga gcggtgaaac gcgcatcacc 360 ggccttctgg aaggcgagga cgtcatcaat acgggcaagg ccatgcaggc catgggcgcc 420 aggatccgta aggaaggcga cacctggatc atcgatggcg tcggcaatgg cggcctcctg 480 gcgcctgagg cgccgctcga tttcggcaat gccgccacgg gctgccgcct gaccatgggc 540 ctcgtcgggg tctacgattt cgacagcacc ttcatcggcg acgcctcgct cacaaagcgc 600 ccgatgggcc gcgtgttgaa cccgctgcgc gaaatgggcg tgcaggtgaa atcggaagac 660 ggtgaccgtc ttcccgttac cttgcgcggg ccgaagacgc cgacgccgat cacctaccgc 720 gtgccgatgg cctccgcaca ggtgaagtcc gccgtgctgc tcgccggcct caacacgccc 780 ggcatcacga cggtcatcga gccgatcatg acgtgcgatc atacggaaaa gatgctgcag 840 ggctttggcg ccaaccttac cgtcgagacg gatgcggacg gcgtgcgcac catccgcctg 900 gaaggccgcg gcaagctcac cggccaagtc atcgacgtgc cgggcgaccc gtcctcgacg 960 gccttcccgc tggttgcggc cctgcttgtt ccgggctccg acgtcaccat cctcaacgtg 1020 ctgatgaacc ccacccgcac cggcctcatc ctgacgctgc aggaaatggg cgccgacatc 1080 gaagtcatca acctgcgcct tgccggcggc gaagacgtgg cggacctgcg cgttcgctcc 1140 tccacgctga agggcgtcac ggtgccggaa gaccgcgcgc ctccgatgat cgacgaatat 1200 ccgattctcg ctgtcgccgc cgccttcgcg gaaggggcga ccgtgatgaa cggtctggaa 1260 gaactccgcg tcaaggaaag cgaccgcctc tcggccgtcg ccaatggcct caagctcaat 1320 ggcgtggatt gcgatgaggg cgagacgtcg ctcgtcgtgc gtggccgccc tgacggcaag 1380 gggctcggca acgcctcggg cgccgccgtc gccacccatc tcgatcaccg catcgccatg 1440 agcttcctcg tcatgggcct cgtgtcggaa aaccctgtca cggtggacga tgccacgatg 1500 atcgccacga gcttcccgga gttcatggac ctgatggccg ggctgggcgc gaagatcgaa 1560 ctctccgata cgaaggctgc cgaaggtaga ggttctcttc ttacttgcgg tgatgttgaa 1620 gaaaaccctg gtcct 1635 <210> 5 <211> 54 <212> DNA <213> Artificial Sequence <400> 5 gaaggtagag gttctcttct tacttgcggt gatgttgaag aaaaccctgg tcct 54 <210> 6 <211> 2025 <212> DNA <213> Artificial Sequence <400> 6 atggcacaaa ttaacaacat ggcacaaggg atacaaaccc ttaatcccaa ttccaatttc 60 cataaacccc aagttcctaa atcttcaagt tttcttgttt ttggatctaa aaaactgaaa 120 aattcagcaa attctatgtt ggttttgaaa aaagattcaa tttttatgca aaagttttgt 180 tcctttagga tttcagcatc agtggctaca gcctgcatgc ttcacggtgc aagcagccgg 240 cccgcaaccg cccgcaaatc ctctggcctt tccggaaccg tccgcattcc cggcgacaag 300 tcgatctccc accggtcctt catgttcggc ggtctcgcga gcggtgaaac gcgcatcacc 360 ggccttctgg aaggcgagga cgtcatcaat acgggcaagg ccatgcaggc catgggcgcc 420 aggatccgta aggaaggcga cacctggatc atcgatggcg tcggcaatgg cggcctcctg 480 gcgcctgagg cgccgctcga tttcggcaat gccgccacgg gctgccgcct gaccatgggc 540 ctcgtcgggg tctacgattt cgacagcacc ttcatcggcg acgcctcgct cacaaagcgc 600 ccgatgggcc gcgtgttgaa cccgctgcgc gaaatgggcg tgcaggtgaa atcggaagac 660 ggtgaccgtc ttcccgttac cttgcgcggg ccgaagacgc cgacgccgat cacctaccgc 720 gtgccgatgg cctccgcaca ggtgaagtcc gccgtgctgc tcgccggcct caacacgccc 780 ggcatcacga cggtcatcga gccgatcatg acgtgcgatc atacggaaaa gatgctgcag 840 ggctttggcg ccaaccttac cgtcgagacg gatgcggacg gcgtgcgcac catccgcctg 900 gaaggccgcg gcaagctcac cggccaagtc atcgacgtgc cgggcgaccc gtcctcgacg 960 gccttcccgc tggttgcggc cctgcttgtt ccgggctccg acgtcaccat cctcaacgtg 1020 ctgatgaacc ccacccgcac cggcctcatc ctgacgctgc aggaaatggg cgccgacatc 1080 gaagtcatca acctgcgcct tgccggcggc gaagacgtgg cggacctgcg cgttcgctcc 1140 tccacgctga agggcgtcac ggtgccggaa gaccgcgcgc ctccgatgat cgacgaatat 1200 ccgattctcg ctgtcgccgc cgccttcgcg gaaggggcga ccgtgatgaa cggtctggaa 1260 gaactccgcg tcaaggaaag cgaccgcctc tcggccgtcg ccaatggcct caagctcaat 1320 ggcgtggatt gcgatgaggg cgagacgtcg ctcgtcgtgc gtggccgccc tgacggcaag 1380 gggctcggca acgcctcggg cgccgccgtc gccacccatc tcgatcaccg catcgccatg 1440 agcttcctcg tcatgggcct cgtgtcggaa aaccctgtca cggtggacga tgccacgatg 1500 atcgccacga gcttcccgga gttcatggac ctgatggccg ggctgggcgc gaagatcgaa 1560 ctctccgata cgaaggctgc cgaaggtaga ggttctcttc ttacttgcgg tgatgttgaa 1620 gaaaaccctg gtcctaaggt tttcggtaga tgtgagttgg ctgccgctat gaagagacac 1680 ggtttggaca actacagagg ttactccttg ggtaactggg tttgtgttgc caagttcgag 1740 tctaacttca acacccaagc tactaacaga aacaccgacg gttctaccga ctacggtatc 1800 ttgcaaatca actccagatg gtggtgtaac gacggtagaa ccccaggttc cagaaacttg tgtaacatcc catgttccgc tttgttgtcc tctgacatca ctgcttccgt taactgtgcc aagaagactc caaacagagc taagagagtt atcactactt tcagaactgg taacagatgt aagggtactg acgtccaagc ctggatcaga ggttgtagat tgtaa <210> 7 <211> 36 <212> DNA <213> Artificial Sequence <400> 7 ctcgagaaaa gaaggtttt cggtagtgt gagttg <210> 8 <211> 33 <212> DNA <213> Artificial Sequence <400> 8 gcggccgctt acaatctaca acctctgatc cag <210> 9 <211> 36 <212> DNA <213> Artificial Sequence <400> 9 ggtaccatgg cacaat ggtaccatgg 36. ggtaccatgg <210> 10 <211> 84 <212> DNA <213> Artificial Sequence <400> 10 aggaccaggg ttttcttcaa catcaccgca agtaagaaga gaacctctac cttcggcagc 60 cttcgtatcg gagagttcga tctt 84 <210> 11 <211> 84 <212> DNA <213> Artificial Sequence <400> 11 gaaggtagag gttctcttct tacttgcggt gatgttgaag aaaaccctgg tcctaaggtt 60 ttcggtagat gtgagttggc tgcc 84 <210> 12 <211> 39 <212> DNA <213> Artificial Sequence <400> 12 ctcgaggcgg ccgcttacaa tctacaacct ctgatccag 39
Claims
1. A modified hen egg white lysozyme, characterized in that: The amino acid sequence of the modified hen egg white lysozyme is shown in SEQ ID NO.
2.
2. A nucleic acid, characterized in that The nucleic acid is used to encode the modified hen egg white lysozyme as claimed in claim 1.
3. The nucleic acid according to claim 2, characterized in that The nucleotide sequence of the nucleic acid is shown in SEQ ID NO.
3.
4. A biomaterial, characterized in that: The biological material comprises the nucleic acid according to claim 2 or 3; The biological material is an expression box, a vector or an engineered bacterium.
5. Use of the modified hen egg white lysozyme according to claim 1, or the nucleic acid according to claim 2 or 3, or the biomaterial according to claim 4 in improving the resistance of cotton to Verticillium dahliae.
6. A method for preparing a transgenic plant, characterized in that: include: The nucleic acid according to claim 2 or 3 is constructed into an expression vector and transformed into a plant; the plant is cotton.
7. A fusion protein gene, characterized in that: The nucleotide sequence of the fusion protein gene is shown in SEQ ID NO.6.
Citation Information
Patent Citations
Representation of high disinfection vitality T4 lysozyme in yeast and producing method thereof
CN101173260A
Engineered gram-negative endolysins
US20210108185A1
